<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 18)*
ABBOTT LABORATORIES
(Name of Issuer)
COMMON SHARES WITHOUT PAR VALUE
-------------------------------
(Title of Class of Securities)
002824 10 0
-----------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / / (A fee is
not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 8 Pages
<PAGE>
CUSIP No. 002824 10 0 13G Page 2 of 8 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Person. S.S. or I.R.S. Identification No. of Above
Person
Abbott Laboratories Stock Retirement Trust
I.R.S. Identification No. 36-6047554
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /X/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Illinois
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 0
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With 60,762,679
--------------------------------------------------
(7) Sole Dispositive Power
0
--------------------------------------------------
(8) Shared Dispositive Power
60,762,679
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
60,762,679
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
7.8%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
EP
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 3 of 8 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Person. S.S. or I.R.S. Identification No. of Above
Person
Gary P. Coughlan
###-##-####
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /X/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 66,504 - (Does not include shares held in
Owned by shares the Abbott Laboratories Stock
Each Reporting direct Retirement Trust for the benefit
Person With of the reporting person.)
--------------------------------------------------
(6) Shared Voting Power
60,963,338 - See Attached Exhibit 1
--------------------------------------------------
(7) Sole Dispositive Power
66,504 shares (see note in 5 above)
direct
--------------------------------------------------
(8) Shared Dispositive Power
60,762,679 - as Co-Trustee, Abbott
Laboratories Stock Retirement
Trust.
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
61,221,169 - (Total of 5 + 6 + 191,327 shares - right to acquire by
exercise of stock options.)
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
7.9%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 4 of 8 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Person. S.S. or I.R.S. Identification No. of Above
Person
Thomas C. Freyman
###-##-####
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /X/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 18,207 shares-(Does not include shares held
Owned by direct in the Abbott Laboratories
Each Reporting Stock Retirement Trust for
Person With for the benefit of the
reporting person.)
--------------------------------------------------
(6) Shared Voting Power
60,963,338 - See Attached Exhibit 1
--------------------------------------------------
(7) Sole Dispositive Power
18,207 shares (see note in 5 above)
direct
--------------------------------------------------
(8) Shared Dispositive Power
60,762,679 - as Co-Trustee, Abbott
Laboratories Stock Retirement
Trust.
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
61,026,093 - (Total of 5 + 6 + 44,458 shares - right to acquire by
exercise of stock options.)
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
7.9%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 5 of 8 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Person. S.S. or I.R.S. Identification No. of Above
Person
Ellen M. Walvoord
###-##-####
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /X/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 31,052 shares-(Does not include shares held
Owned by direct in the Abbott Laboratories
Each Reporting Stock Retirement Trust for
Person With for the benefit of the
reporting person.)
--------------------------------------------------
(6) Shared Voting Power
60,963,338 - See Attached Exhibit 1
--------------------------------------------------
(7) Sole Dispositive Power
31,052 shares (see note in 5 above)
direct
--------------------------------------------------
(8) Shared Dispositive Power
60,762,679 - as Co-Trustee, Abbott
Laboratories Stock Retirement
Trust.
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
61,049,498 - (Total of 5 + 6 + 55,108 shares - right to acquire by
exercise of stock options.)
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
7.9%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Item 1(a) Name of Issuer:
Abbott Laboratories
Item 1(b) Address of Issuer's Principal Executive Offices:
100 Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(a) Name of Persons Filing:
Abbott Laboratories Stock Retirement Trust
Gary P. Coughlan
Thomas C. Freyman
Ellen M. Walvoord
Item 2(b) Address of Principal Business Office:
100 Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(c) Citizenship:
Abbott Laboratories Stock Retirement Trust - Illinois.
Gary P. Coughlan, Thomas C. Freyman, and
Ellen M. Walvoord - United States
Item 2(d) Title of Class of Securities:
Common shares without par value
Item 2(e) CUSIP Number:
002824 10 0
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or
13d-2(b), check whether the person filing is an:
[X] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974.
Item 4. Ownership:
(a) (See cover pages 2, 3,
(b) 4 and 5, Items 5 through
(c) 9 and 11.)
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable.
Page 6 of 8 Pages
<PAGE>
Item 6. Ownership of More than Five Percent on Behalf of Another
Person:
The shares owned by the Abbott Laboratories Stock Retirement
Trust and the dividends thereon are held for the benefit of
participants of the Abbott Laboratories Stock Retirement Plan
pursuant to terms of that Plan and the Trust. The Abbott
Laboratories Stock Retirement Plan is a qualified profit sharing
plan. As of December 31, 1996, there were 36,404 participants
with share balances in the Plan.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
Not applicable.
Item 8. Identification and Classification of Members of the Group:
Not applicable.
Item 9. Notice of Dissolution of Group:
Not applicable.
Item 10. Certification:
Not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
This statement is filed on behalf of each individual listed below pursuant to
their agreement.
February 10, 1997
---------------------------------
Date
/s/ Gary P. Coughlan
- ----------------------------- ABBOTT LABORATORIES STOCK
Gary P. Coughlan RETIREMENT TRUST
/s/ Thomas C. Freyman
- -----------------------------
Thomas C. Freyman
/s/ Ellen M. Walvoord /s/ Thomas C. Freyman
- ----------------------------- ---------------------------------
Ellen M. Walvoord Thomas C. Freyman, Chairman of
Trustees, Abbott Laboratories
Stock Retirement Trust
Page 7 of 8 Pages
<PAGE>
EXHIBIT 1
Schedule 13G
Amendment No. 18
Abbott Laboratories
Common shares without par value
CUSIP Number 002824 10 0
Messrs. Coughlan and Freyman and Ms. Walvoord are Co-trustees of the Abbott
Laboratories Stock Retirement Trust, committee members of a committee
established under the Abbott Laboratories Stock Retirement Trust (Puerto Rico),
Trustees of the Abbott Laboratories Employee Benefit Trust, and members of the
Abbott Stock Committee for the Abbott Laboratories Ashland Union 401(k) Trust.
As such, each of them has shared voting power over the 60,963,338 shares held by
those trusts. This total is comprised of the following components:
Number of Shares Name of Trust
---------------- -------------
60,762,679 Abbott Laboratories Stock Retirement Trust
172,962 Abbott Laboratories Stock Retirement Trust
(Puerto Rico)
26,000 Abbott Laboratories Employee Benefit Trust
1,697 Abbott Laboratories Ashland Union 401(k) Trust
Page 8 of 8 Pages
<PAGE>
Disclaimer of Beneficial Ownership
Under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 18 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned is,
for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the
beneficial owner of any securities covered by the Schedule. Pursuant to Rule
13d-4 of the Act, the undersigned disclaims such ownership with respect to any
shares listed therein of which he would not otherwise be deemed to be beneficial
owner.
/s/ Gary P. Coughlan
----------------------------
Gary P. Coughlan
February 10, 1997
----------------------------
Date
<PAGE>
Disclaimer of Beneficial Ownership
Under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 18 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned is,
for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the
beneficial owner of any securities covered by the Schedule. Pursuant to Rule
13d-4 of the Act, the undersigned disclaims such ownership with respect to any
shares listed therein of which he would not otherwise be deemed to be beneficial
owner.
/s/ Thomas C. Freyman
----------------------------
Thomas C. Freyman
February 10, 1997
----------------------------
Date
<PAGE>
Disclaimer of Beneficial Ownership
Under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 18 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned is,
for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the
beneficial owner of any securities covered by the Schedule. Pursuant to Rule
13d-4 of the Act, the undersigned disclaims such ownership with respect to any
shares listed therein of which she would not otherwise be deemed to be
beneficial owner.
/s/ Ellen M. Walvoord
----------------------------
Ellen M. Walvoord
February 10, 1997
----------------------------
Date